SCHEMBL1572491

SCHEMBL1572491

CC1(C)Cc2ccc(C#N)cc2C1NC(=O)c1cc2cc(Cl)ccc2[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 1.00
SMYD3 Q9H7B4 2/20 0.47
PYGL P06737 14/20 0.46
PYGM P11217 11/20 0.46
HRH4 Q9H3N8 2/20 0.45
HRH3 Q9Y5N1 1/20 0.43
EHMT2 Q96KQ7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1572488 1.00 CNR2 (1.00) CNR2SMYD3PYGLPYGMHRH4
SCHEMBL1572570 0.90 CNR2 (0.81) CNR2PYGLPYGMHRH4
SCHEMBL1572945 0.90 CNR2 (0.81) CNR2PYGLPYGMHRH4
SCHEMBL1572567 0.90 CNR2 (0.81) CNR2PYGLPYGMHRH4
SCHEMBL1572545 0.89 CNR2 (0.80) CNR2SMYD3PYGLPYGMHRH4
SCHEMBL1572553 0.89 CNR2 (0.80) CNR2PYGLPYGMHRH4
SCHEMBL1572554 0.89 CNR2 (0.80) CNR2PYGLPYGMHRH4
SCHEMBL1573069 0.89 CNR2 (0.80) CNR2SMYD3PYGLPYGMHRH4
SCHEMBL1572622 0.88 CNR2 (0.78) CNR2PYGLPYGM
SCHEMBL1572620 0.88 CNR2 (0.78) CNR2PYGLPYGM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943658-B2 Indole indane amide compounds useful as CB2 agonists and method BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-17 US disclosed
US-7943658-B2 Indole indane amide compounds useful as CB2 agonists and method BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-17 US disclosed
US-7943658-B2 Indole indane amide compounds useful as CB2 agonists and method BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-17 US disclosed
EP-2176221-B1 INDOLE INDANE AMIDE COMPOUNDS USEFUL AS CB2 AGONISTS AND METHOD BRISTOL MYERS SQUIBB CO (US) 2011-04-13 EP disclosed
EP-2176221-A1 INDOLE INDANE AMIDE COMPOUNDS USEFUL AS CB2 AGONISTS AND METHOD Bristol-Myers Squibb Company (US) 2010-04-21 EP disclosed
US-20090041722-A1 INDOLE INDANE AMIDE COMPOUNDS USEFUL AS CB2 AGONISTS AND METHOD BRISTOL-MYERS SQUIBB COMPANY 2009-02-12 US disclosed
US-20090041722-A1 INDOLE INDANE AMIDE COMPOUNDS USEFUL AS CB2 AGONISTS AND METHOD BRISTOL-MYERS SQUIBB COMPANY 2009-02-12 US disclosed
US-20090041722-A1 INDOLE INDANE AMIDE COMPOUNDS USEFUL AS CB2 AGONISTS AND METHOD BRISTOL-MYERS SQUIBB COMPANY 2009-02-12 US disclosed
WO-2009015169-A1 INDOLE INDANE AMIDE COMPOUNDS USEFUL AS CB2 AGONISTS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090041722-A1 INDOLE INDANE AMIDE COMPOUNDS USEFUL AS CB2 AGONISTS AND METHOD CNR2, CNR1, GPR68 CNR2 1/4885SMYD3 2865/4885PYGL 3829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.